Skip to content
OccuflowBIO
01legal

Privacy Policy

Last updated: August 2026. This policy describes how OccuFlow Bio, Inc. collects, uses, and protects information submitted through this website.

Information we collect

We collect information you submit through the inquiry form on this website, such as your name, email address, organization, and message. We may also collect standard technical information, such as IP address and browser type, through analytics tools that help us understand how the site is used.

How we use information

We use submitted information to respond to inquiries, evaluate potential scientific, investor, or partnership interest, and improve the content and usability of this website. We do not use this site to collect patient information or to provide medical advice.

Disclosure of information

We do not sell personal information. We may share it with service providers who process data on our behalf under contract, or where required by law or to protect our rights. Information submitted through this site may be reviewed by team members and authorized partners involved in evaluating inquiries.

Cookies and analytics

This website uses minimal cookies and analytics to measure traffic and site performance. You can control cookies through your browser settings. Disabling cookies may affect some site functionality.

Data retention

We retain submitted information for as long as necessary to fulfill the purpose for which it was collected, to respond to inquiries, and to meet legal or operational requirements.

Your choices

You may request access to, correction of, or deletion of personal information you have submitted by contacting us at the email addresses listed below. Where required by law, we will respond to verified requests within a reasonable timeframe.

Security

We apply reasonable technical and organizational safeguards to protect submitted information. No method of transmission or storage is completely secure, and we cannot guarantee absolute security.

Children

This website is not directed to children, and we do not knowingly collect information from children.

Changes to this policy

We may update this policy from time to time. The most recent revision date appears at the top of this page. Continued use of the website after changes indicates acceptance of the updated policy.

Contact

Questions about this policy can be directed to gzode@hs.uci.edu or mike@octaneoc.org.

OccuflowBIO

A preclinical-stage ophthalmic biotechnology company developing OF-01 to restore the eye's natural drainage architecture in glaucoma.

contact
  • gzode@hs.uci.edu
  • mike@octaneoc.org
  • 505(b)(2) regulatory pathway
investigational product disclaimer

OF-01 is an investigational new drug candidate. It has not been approved by the U.S. Food and Drug Administration or any other regulatory authority and has not been demonstrated to be safe or effective for any use. All data described on this website are preclinical. Information provided is for scientific, corporate, and qualified-investor purposes only and is not medical advice.

important disclosures

Preclinical Data: Results described are from in vitro, ex vivo human donor tissue, and animal models, some unpublished. Preclinical findings do not reliably predict results in humans.

Forward-Looking Statements: Statements on development plans, regulatory pathway, timelines, and potential outcomes are forward-looking and subject to substantial uncertainty.

No Offer of Securities: This website is not an offer to sell or a solicitation to buy any security.

No Third-Party Endorsement: Universities and institutions named (including UC Irvine) are identified for background only and do not endorse OccuFlow Bio or OF-01.

© 2026 OccuFlow Bio. All rights reserved.
PRECLINICAL · OF-01 · OPHTHALMOLOGY

Research conducted at UC Irvine (no endorsement implied). OF-01 is an investigational product. Safety and efficacy have not been established.